Form 4 for STLN Starling Oncology, Inc.
Accepted 2023-11-15 00:00:00 ET · period of report 2023-11-13 · accession 0001628280-23-039192 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-15 | 2023-11-13 | STLN | Hively Brad | Dir | S - Sale+OE | $2.52 | -47.0K | 724.2K | -6% | -$118.4K |
| D | 2023-11-15 | 2023-11-13 | STLN | Hively Brad | Dir | M - OptEx | $0.85 | +47.0K | 771.2K | +6% | +$40.0K |
| D | 2023-11-15 | 2023-11-14 | STLN | Hively Brad | Dir | D - Sale to Iss | $2.39 | -27.1K | 697.1K | -4% | -$64.8K |
| D | 2023-11-15 | 2023-11-13 | STLN | Hively Brad | Dir | M - OptEx | $0.00 | -47.0K | 1.77M | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2023-11-13 | S | D | 47,000 | $2.52 | 724,182 | D | — | — | |
| 2 | Common | Common stock | 2023-11-13 | M | A | 47,000 | $0.85 | 771,182 | D | — | — | |
| 3 | Common | Common stock | 2023-11-14 | D | D | 27,117 | $2.39 | 697,065 | D | — | — | |
| 4 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-11-13 | M | D | 47,000 | $0.00 | 1,770,431 | D | $0.85 · — to 2029-12-02 | 47,000 Common stock | (F1) These options vest as to 1/4th of the total number of shares subject to the option on the first anniversary of December 2, 2019 (the "Original Grant Date"), and as to 1/36th of the total number of shares monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Original Grant Date, subject to continued employment through the vest date. |